Compounding Pharmacy Bill Clears Senate Procedural Hurdle

Legislation that would broaden federal regulation of compounding pharmacies like the one linked to last year’s meningitis deaths cleared a procedural hurdle in the U.S. Senate and could be on the desk of President Barack Obama within days.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.